PTC Therapeutics | PTCT - EPS - Lucro por Ação


Fiscal Calendário Atual Consenso Anterior Data
FY2026Q3 Sep/2025 0.27 0.20 Oct/22
FY2026Q2 Jun/2026 0.92 0.32 -0.83 Jul/30
FY2026Q1 Mar/2026 -0.03 -0.43 10.04 May/07
FY2025Q4 Dec/2025 -1.67 -0.47 -0.85 Feb/19
FY2025Q3 Sep/2025 0.20 -1.02 -1.39 Nov/04




Eps Alterar Data
Acadia Pharmaceuticals USD 0.18 0.16 2026-06
Alnylam Pharmaceuticals USD 1.84 0.15 2026-06
Amgen USD 6.29 1.14 2026-06
BioCryst Pharmaceuticals USD 0.3 0.87 2026-06
Biogen USD 3.6 0.03 2026-06
BioMarin Pharmaceutical USD 1.2 0.44 2026-06
Cytokinetics USD -1.5 0.17 2026-06
Daiichi Sankyo JPY 37.72 11.03 2026-06
Enanta Pharmaceuticals USD -1.05 0.31 2024-12
Gilead Sciences USD -6.75 8.78 2026-06
Incyte USD 3.09 1.28 2026-06
Ionis Pharmaceuticals USD -0.69 0.13 2026-06
Ironwood Pharmaceuticals USD 0.31 0.07 2026-06
Karyopharm Therapeutics USD -1.02 1.2 2026-03
Novartis USD 2.41 0.42 2026-06
Pfizer USD 0.77 0.02 2026-06
PTC Therapeutics USD 0.92 0.95 2026-06
Puma Biotechnology USD 0.41 0.5 2024-09
Roche Holding CHF 10.98 2.61 2026-06
Sangamo BioSciences USD -0.18 0.1 2024-06
Sarepta Therapeutics USD 0.64 2.52 2026-06
TG Therapeutics USD 0.05 0.07 2026-06
Ultragenyx Pharmaceutical USD -0.9 0.94 2026-06
Vertex Pharmaceuticals USD 4.73 0.26 2026-06
Xencor USD -0.29 1.42 2026-06